UCNT: Chemocurable sometimes, but not very often
- 1 August 1997
- journal article
- Published by Elsevier
- Vol. 8 (8) , 723-725
- https://doi.org/10.1023/a:1008296203723
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT)Annals of Oncology, 1997
- Clonal Proliferations of Cells Infected with Epstein–Barr Virus in Preinvasive Lesions Related to Nasopharyngeal CarcinomaNew England Journal of Medicine, 1995
- Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspectsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma.Journal of Clinical Oncology, 1993
- Computed Tomographic Density of Metastatic Lymph Nodes as a Treatment-Related Prognostic Factor in Advanced Head and Neck CancerJNCI Journal of the National Cancer Institute, 1991
- Computed tomography in nasopharyngeal carcinoma: Part II: Impact on survivalInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Diet, living conditions and nasopharyngeal carcinoma in tunisia—a case-control studyInternational Journal of Cancer, 1990
- Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiationNature, 1990
- Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2Journal of Virology, 1989
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984